BillionToOne (BLLN) Return on Invested Capital (2026)
BillionToOne (BLLN) posted Return on Invested Capital of 0.4% for Q1 2026.
BillionToOne (BLLN) Return on Invested Capital (2026) Analysis & Trends
BillionToOne has reported Return on Invested Capital for 1 years, with the latest figure at 0.4% in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 0.01% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 0.02% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 0.01% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 0.02% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 0.00% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -0.01% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 0.04% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 0.01% |
| 10 | BillionToOne | 6.82 Bn | 6.28 Bn | 79.10 Mn | 0.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.40% |